This first comprehensive MDSGene review is devoted to the 3 autosomal recessive Parkinson's
disease forms: PARK‐Parkin, PARK‐PINK1, and PARK‐DJ1. It followed MDSGene's …

Objective: To examine whether gene expression analysis of a large-scale Parkinson
disease (PD) patient cohort produces a robust blood-based PD gene signature compared to …

Background Human genetics research lacks diversity; over 80% of genome‐wide association
studies have been conducted on individuals of European ancestry. In addition to limiting …

With newly rising coronavirus disease 2019 (COVID-19) cases, important data gaps remain
on (i) long-term dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…

Background Genetic stratification of Parkinson's disease (PD) patients facilitates gene‐tailored
research studies and clinical trials. The objective of this study was to describe the design …

Introduction Harmonizing data across cohorts is important for validating findings or combining
data in meta‐analyses. We replicate and validate a previous conversion of MoCA to …

Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay
of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to …

This Movement Disorder Society Genetic mutation database Systematic Review focuses on
monogenic atypical parkinsonism with mutations in the ATP13A2, DCTN1, DNAJC6, FBXO7, …

Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Genetic modifiers,
environmental factors and gene–environment interactions have been found to modify PD risk …

Parkinson’s disease is increasingly viewed as a complex disorder including a range of
typical non-motor symptoms in addition to the cardinal motor signs. This cohort was set up in …